MeSH D013530 - surgical wound infection
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Abbott Biotherapeutics | Metronidazole | Metronidazole |  | 1983-11-18 |  |  |
| Able Laboratories | Metronidazole | Metronidazole |  | 2003-06-25 |  |  |
| Alcon Research | Povidone-iodine | Betadine |  | 1986-12-17 |  |  |
| Alembic Pharmaceuticals | Metronidazole | Metronidazole |  | 2009-06-23 |  |  |
| Alkem Laboratories | Cefuroxime axetil | Cefuroxime Axetil |  | 2010-06-07 |  |  |
| Cephalexin | Cephalexin |  | 2010-12-20 |  |  | |
| Allegiance Healthcare | Povidone-iodine | Povidone |  | 1989-03-31 |  |  |
| Allergan | Ampicillin | Ampicillin |  | 1988-10-24 |  |  |
| Cefuroxime | Cefuroxime |  | 1993-02-26 |  |  | |
| Metronidazole | Metronidazole |  | 1984-12-20 |  |  | |
| Amneal Pharmaceuticals | Metronidazole | Metronidazole |  | 2023-05-24 |  |  |
| ANDA Repository | Cefuroxime axetil | Cefuroxime Axetil |  | 2008-02-15 |  |  |
| Cephalexin | Cephalexin |  | 2005-06-28 |  |  |
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
56%5/9
Phase 2
80%12/15
Phase 3
65%24/37
Approved: 11Overall Success rate: 29%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use